Infliximab Therapeutic Mixture from China
A mixed immunological preparation containing infliximab monoclonal antibodies for autoimmune diseases like Crohn's. It is supplied in bulk, not in measured doses or retail packings, and qualifies as a mixed immunological product under chapter note 2.
Duty Rate — China → Canada
0%
Import Tips
• Provide documentation showing the product is a mixture containing infliximab MABs, as per chapter note 2
• Ensure it is not for retail sale
• Verify any Health Canada requirements for biological products before import